🇺🇸 FDA
Patent

US 10195165

Methods of treating Prader-Willi syndrome

granted A61KA61K31/145

Quick answer

US patent 10195165 (Methods of treating Prader-Willi syndrome) held by OVID THERAPEUTICS INC. expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/145